drugset / Trial / NCT03955705

Analgesic Effectiveness of Nefopam in Patients Undergoing Anterior Cervical Spine Surgery

NCT03955705

Unknown 50 enrolled Mahidol University
RandomizedParallel-groupTriple-blindTreatment

Summary

Nefopam is a benzoxazocine derivative which is non-opioid and non NSAIDs. The previous studies showed that nefopam can inhibit reuptake of serotonin, norepinephrine and dopamine. It has no respiratory depression so may be useful in potential airway compromized surgery like anterior cervical discectomy and fusion (ACDF). This study aims to study the analgesic properties of nefopam after ACDF.

Timeline

Start
2019-05-15
Primary completion
2021-04-30
Completion
2021-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 20 mg Intravenous